德美医疗完成近1.5亿元E轮融资_Partners_News

德美医疗完成近1.5亿元E轮融资

2021-02-18

近日，恒旭资本投资案例德美医疗宣布完成近1.5亿元人民币E轮融资，距离上次融资不到半年时间。本轮融资由鼎晖投资领投，现有股东方启明创投和博行资本跟投。

德美医疗联合创始人兼董事长黎建波表示，国内对运动医学的关注虽然比国外起步晚，但是发展非常迅速，运动医学已逐渐成长为最具潜力的医疗器械细分领域之一。在获得本轮融资后，公司将继续响应国家创新驱动发展的战略，集众智、成大事，努力填补国内技术空白，打造国产高端医疗器械品牌。在不断发展壮大的同时，德美医疗未来将持续扎根于运动医学领域，预防、治疗、康复、教育并重，成为践行社会责任和创造国际荣誉的中国运动医学品牌。

目前，德美医疗已在北京、四川、辽宁等三地均已建成高质量、高效率的现代化生产基地及研发中心。技术方面围绕新材料和微创技术两大运动医学核心领域，自主研发的核心产品采用独创工艺，拥有更符合人体结构的生物力学设计，使用最先进的精密复合材料，公司从原料采购、加工技术、工艺流程、表面处理等各个环节严格落实质量控制程序，确保每一个产品安全、顺利地应用于手术之中。

Address：5th Floor, Building N3, New Bund Square City, No. 2, Lane 131, Qiantan Avenue, Pudong New District, Shanghai

Email：scir@hengxucapital.com

Change of Address Notice

Dear investors and partners,

With your ongoing care and support, Hengxu Capital has achieved significant development and progress since its establishment. In order to better meet the needs of our business operations, our office location will be relocated to 5F, Building N3, New Bund Square City, No. 2, Lane 131, Qiantan Avenue, Pudong New District, Shanghai(Map Link: https://j.map.baidu.com/b5/x7VK).

The new office space is conveniently located with excellent facilities, providing improved conditions for meetings, receptions, and work. This relocation will facilitate better communication and collaboration between Hengxu Capital and our partners, enhancing employee satisfaction and office efficiency, and laying a solid foundation for continued and rapid business development.

The new office has been officially in use since January 29, and our mailing address has been switched to the new location. Considering the approaching Chinese New Year, we will not hold a relocation ceremony at the moment but plan to invite you to visit and guide us at a suitable time in the future.

If you have any questions or concerns, please feel free to contact us. Our phone numbers and email addresses remain unchanged. Once again, we appreciate your support and understanding, and we look forward to creating a brighter future together.

Shanghai SAIC Hengxu Capital Co., Ltd.

Jan. 29, 2024